Back
Vor Biopharma, Inc. Stock Predictions
Most Pre-IPO Big Tech Shifts Look Like This at the Start
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com
Sell
22
VOR
Vor Biopharma, Inc.
Last Price:
$13.20
Seasonality Move:
-36.85%
7 Day Trial
ALL ACCESS PASS
$
7
This Critical Mineral's Up 122% in the Last 12 Months.
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atVor Biopharma, Inc. Stock Forecast
-
Over the next 52 weeks, Vor Biopharma, Inc. has on average historically fallen by 52.4% based on the past 5 years of stock performance.
-
Vor Biopharma, Inc. has fallen lower in 5 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is Vor Biopharma, Inc. Stock Undervalued?The current Vor Biopharma, Inc. [VOR] share price is $13.16. The Score for VOR is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
VOR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Vor Biopharma, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Vor Biopharma, Inc. has on average historically fallen by 52.4% based on the past 5 years of stock performance.
Vor Biopharma, Inc. Stock Rating
Sell
22
Vor Biopharma, Inc. (VOR)
is a Sell
Is Vor Biopharma, Inc. overpriced?
-
Vor Biopharma, Inc. has fallen lower in 5 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
Vor Biopharma, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vorbio.com
52-Week Data
52-Week High:
65.80
52-Week Low:
2.62
Prediction Charts
Market Cap:
90M
Price in USD:
13.16
Volume:
1M
Beta:
2.05
Technical Analysis
SMA50:
12.65
SMA100:
19.10
SMA200:
22.36
52-Wk Change:
-56.13%
Stock Predictions
-
Is Vor Biopharma, Inc. stock public?Yes, Vor Biopharma, Inc. is a publicly traded company.
-
What is the Vor Biopharma, Inc. stock quote today?The Vor Biopharma, Inc. stock price is 13.16 USD today.
-
How to buy Vor Biopharma, Inc. stock online?You can buy Vor Biopharma, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-20 | 15.21 | 17.60 | 18.50 | 14.94 |
| Jan-21 | 17.69 | 18.08 | 18.60 | 16.95 |
| Jan-22 | 18.20 | 17.27 | 18.27 | 17.07 |
| Jan-23 | 17.19 | 16.59 | 17.64 | 16.40 |
| Jan-26 | 16.44 | 15.07 | 16.44 | 14.79 |
| Jan-27 | 15.00 | 14.76 | 15.10 | 14.24 |
| Jan-28 | 14.50 | 13.74 | 14.75 | 13.71 |
| Jan-29 | 13.70 | 13.99 | 14.11 | 13.30 |
| Jan-30 | 14.55 | 13.00 | 15.00 | 12.90 |
| Feb-2 | 12.84 | 12.79 | 13.47 | 12.35 |
| Feb-3 | 12.79 | 12.82 | 13.16 | 12.21 |
| Feb-4 | 12.80 | 12.40 | 12.88 | 12.07 |
| Feb-5 | 12.28 | 12.07 | 12.63 | 11.46 |
| Feb-6 | 12.31 | 13.16 | 13.80 | 12.25 |
Vor Biopharma, Inc. Earnings
Vor Biopharma, Inc. Earnings Report: Per Share Vor Biopharma, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Vor Biopharma, Inc. Forecast Revenue Growth
Vor Biopharma, Inc. Stock Analysis: Historical quarterly revenues per share for Vor Biopharma, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $2.88 per share, a decrease next quarter of $0.00 per share, an increase this year of $97.92 per share, and a decrease next year of $1.12 per share.
* Vor Biopharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.